The MarketWatch News Department was not involved in the creation of this content. -- Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik(R) ...
Valinor Pharma said today it was purchased by German pharmaceutical company Grünenthal for about $250 million in upfront cash consideration. Chicago-based Valinor makes Movantik, a prescription ...
Valinor’s academic collaborations with the Montgomery and Theis Labs will establish industry-standard benchmarks for assessing the clinical translatability of perturbation prediction models SALT LAKE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback